Status:
COMPLETED
Preemptive Analgesia With Celecoxib for Acute Dental Pain Management
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Pain, Postoperative
Eligibility:
All Genders
18-45 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the effect on postoperative pain of a single agent nonsteroidal anti-inflammatory drug (NSAID) \[celecoxib plus placebo\] to an NSAID combination \[celecoxib pl...
Detailed Description
This randomized, double-blind, placebo-controlled, prospective clinical trial is designed to compare the postoperative pain reduction of a single agent nonsteroidal anti-inflammatory drug (NSAID) and ...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status classification 1 or 2
- at least 1 impacted mandibular third molar planned for extraction
Exclusion
- ASA 3 or higher for physical status classification
- severe pericoronitis associated with third molar to be extracted
- any known allergies to NSAIDs, aspirin, acetaminophen, sulfa drugs
- history of cardiovascular or cerebrovascular disease
- hepatic disease or impairment
- pregnancy
Key Trial Info
Start Date :
April 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT04790812
Start Date
April 22 2021
End Date
March 1 2023
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030